Ketorolac Suppresses Postoperative Bladder Spasms After Pediatric Ureteral Reimplantation

Authors:
  • JPJohn M. Park
    John M. Park
  • CHConstance S. Houck
    Constance S. Houck
  • NSNavil F. Sethna
    Navil F. Sethna
  • LSLorna J. Sullivan
    Lorna J. Sullivan
  • AAAnthony Atala
    Anthony Atala
  • JBJoseph G. Borer
    Joseph G. Borer
  • BCBartley G. Cilento
    Bartley G. Cilento
  • DDDavid A. Diamond
    David A. Diamond
  • CPCraig A. Peters
    Craig A. Peters
  • ARAlan B. Retik
    Alan B. Retik
  • SBStuart B. Bauer
    Stuart B. Bauer

Abstract
D randomization. Twelve patients in each group shared similar preoperative characteristics. All were maintained on an epidural infusion of bupivacaine (0.1%) with fentanyl (2 μg/mL) throughout the study. Patients were given either ketorolac (0.5 mg · kg-1 · dose-1) or placebo (equivalent volume saline) IV after surgery and every 6 h thereafter for 48 h. Parents were instructed to record bladder spasm episodes prospectively by using a standardized time-flow diary. Three patients (25%) in the ketorolac group experienced bladder spasms, compared with 10 patients (83%) in the placebo group (two-sided P < 0.05). The median severity score for the ketorolac group was 1.2 (mild = 1.0, severe = 3.0), compared with 2.6 for the placebo group (P = 0.003). We conclude that IV ketorolac reduces the frequency and severity of postoperative bladder spasms after intravesical ureteroneocystostomy. Implications We studied the efficacy of ketorolac, a prostaglandin synthesis inhibitor, in the treatment of bladder spasm after ureteroneocystostomy (antireflux operation). Patients were randomized in a double-blinded manner to receive either ketorolac or placebo after the surgery. We demonstrate that ketorolac reduces the frequency and severity of postoperative bladder spasm....

This publication has 12 references indexed in Scilit: